INFECTIVE ENDOCARDITIS IN THE PRESENCE OF HYPERTROPHIC CARDIOMYOPATHY: CLINICAL CASES
https://doi.org/10.17650/1818-8338-2014-1-53-57
Abstract
The paper describes 2 cases that demonstrate the patterns and specific features of infective endocarditis in the presence of hypertrophic obstructive cardiomyopathy, diagnostic difficulties, comorbidities, as well as error analysis and a disease outcome
About the Authors
Ye. Yu. PonomarevaRussian Federation
N. M. Nikitina
Russian Federation
S. V. Landfang
Russian Federation
References
1. Филиппов Е.В., Якушин С.С. Гипертрофическая кардиомиопатия: основы диагностики и лечения. Клиницист 2007;(3):7–14.
2. Габрусенко С.А. Гипертрофическая кардиомиопатия: современное состояние проблемы. Consilium Мedicum 2004;(5):350–5.
3. Maron B.J., McKenna W.J., Danielson G.K. et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42(9):1687–713.
4. Амосова Е.Н. Кардиомиопатия. К.: Книга плюс, 1999.
5. Spirito P., Rapezzi C., Bellone P. et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis Circulation 1999;99(16):2132–7.
6. Morgan-Hughes G., Motwani J. Mitral valve endocarditis in hypertrophic cardiomyopathy: case report and literature review. Heart 2002;87(6):e8.
7. Alessandri N., Pannarale G., Del Monte F. et al. Hypertrophic obstructive cardiomyopathy and infective endocarditis: A report of seven cases and a review of the literature. Eur Heart J 1990;11(11):1041–8.
8. Louahabi T., Drighil A., Habbal R., Azzouzi L. Infective endocarditis complicating hypertrophic obstructive cardiomyopathy. Eur J Echocardiogr 2006;7(6):468–70.
9. Habib G., Hoen B., Tornos P. et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30(19):2369–413.
10. Козлов Р.С., Дехнич А.В. Комментарии к Рекомендациям по антимикробной терапии эндокардита Британского общества по антимикробной химиотерапии применительно к России: что нужно иметь в виду? Сердце 2006;5(8):411–2.
11. Виноградова Т.Л. Инфекционный эндокардит: современное течение. Клиницист 2011;(3):4–9.
12. Филиппенко П.С., Драгоман Е.А. Инфекционный эндокардит у инъекционных наркоманов. Часть 2. Особенности клинической картины, диагностики и лечения. Клин мед 2010;(2):22–9.
13. Демин А.А., Демин А.А. Бактериальные эндокардиты. М.: Медицина, 1978.
14. Gebo K.A., Burkey M.D., Lucas G.M. et al. Incidence of, risk factors for clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 2006;43(4):426–32.
15. Пономарева Е.Ю., Рощина А.А., Ребров А.П. Особенности течения инфекционного эндокардита на фоне ВИЧ/СПИДа у инъекционных наркоманов. Клиницист 2011;(3):19–22.
Review
For citations:
Ponomareva Ye.Yu., Nikitina N.M., Landfang S.V. INFECTIVE ENDOCARDITIS IN THE PRESENCE OF HYPERTROPHIC CARDIOMYOPATHY: CLINICAL CASES. The Clinician. 2014;8(1):53-57. (In Russ.) https://doi.org/10.17650/1818-8338-2014-1-53-57